Form EFFECT Adverum Biotechnologies,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 |
| Accession Number: | 0001193125-25-312780 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RayNeo GT Max Launches in Canada, Bringing Up to a 307-Inch Personal Cinema Experience
- F3 Announces Grant of Stock Options and Restricted Share Units
- Leading Digital Wallet for Travelers and Expats, Moreta, Introduces Peer-to-Peer Transfers via Moreta Tags and QR Codes
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share